Interestingly, we recently found autoantibodies to PAD2 in a subset of people with RA with less severe and progressive joint disease (19), suggesting that anti-PAD2 antibodies may attenuate the pathogenic role of PAD2 in RA. The gene discussed is PADI2; the disease is rheumatoid arthritis.